Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing unnecessary animal testing, today voiced serious concerns over the U.S.

Leverage AI as a personalised "code coach" to bridge the gap between manual testing and automation by translating plain English into executable scripts and providing line-by-line logic explanations.

For years, many platforms treated unilateral online terms updates as a checklist item: revise the terms, post the new version, email notice, and ...

Our borders are a test lab for technology and surveillance policies, but how far are we willing to let the government use ...

Wisconsin police will soon be allowed to conduct roadside saliva testing for marijuana and other illegal substances. Supporters say the new law will help strengthen cases against suspected drugged ...

MSU hosted the inaugural panel of the Presidential Speakers Series moderated by President Kevin Guskiewicz with panelists ...

Q4 and full-year 2025 financial results, “Everything we’ve built over the past 7 years is converging, and our strategy is paying off in ways the market is only beginning to understand,” shares founder ...

Over the course of the past decade, a tremendous amount of progress has been made both socially and legally when it comes to ...

One morning in May 2019, a cardiac surgeon stepped into the operating room at Boston Children’s Hospital more prepared than ever before to perform a high-risk procedure to rebuild a child’s heart. The ...

The Uncertainty Engine is guiding research in fusion plasma physics. Could similar approaches benefit fission research as well?

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...